Anna Ehinger

All Stories

1. 
   NeoCircle: pre- and post-operative circulating tumor DNA dynamics predicts survival in neoadjuvant-treated early breast cancer

   Article • EMBO Molecular Medicine, May 2026, Springer Science + Business Media

   Anna Ehinger

2. 
   Navigating discrepancies: The assessment of residual lymphovascular invasion in breast carcinoma after neoadjuvant treatment

   Article • The Breast, August 2025, Elsevier

   Anna Ehinger

3. 
   Data from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

   Article • July 2025, American Association for Cancer Research (AACR)

   Anna Ehinger

4. 
   Supplementary Figure S1 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

   Article • July 2025, American Association for Cancer Research (AACR)

   Anna Ehinger

5. 
   Supplementary Figure S10 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

   Article • July 2025, American Association for Cancer Research (AACR)

   Anna Ehinger

6. 
   Supplementary Figure S2 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

   Article • July 2025, American Association for Cancer Research (AACR)

   Anna Ehinger

7. 
   Supplementary Figure S3 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

   Article • July 2025, American Association for Cancer Research (AACR)

   Anna Ehinger

8. 
   Supplementary Figure S4 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

   Article • July 2025, American Association for Cancer Research (AACR)

   Anna Ehinger

9. 
   Supplementary Figure S5 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

   Article • July 2025, American Association for Cancer Research (AACR)

   Anna Ehinger

10. 
    Supplementary Figure S6 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

11. 
    Supplementary Figure S7 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

12. 
    Supplementary Figure S8 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

13. 
    Supplementary Figure S9 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

14. 
    Supplementary Methods 1 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

15. 
    Supplementary Tables 1 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

16. 
    Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • Clinical Cancer Research, April 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

17. 
    A bottom-up initiated digital external quality assessment scheme for the state-of-the-art pathology in Sweden: reduced variability between pathology departments

    Article • Virchows Archiv, February 2025, Springer Science + Business Media

    Anna Ehinger

18. 
    Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohort

    Article • Breast Cancer Research and Treatment, December 2024, Springer Science + Business Media

    Anna Ehinger

19. 
    The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?

    Article • EClinicalMedicine, December 2024, Elsevier

    Anna Ehinger

20. 
    Monitoring ctDNA dynamics in early breast cancer using a novel ultra-sensitive tumor-informed structural variant approach combining whole-genome sequencing and multiplex dPCR.

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Anna Ehinger

21. 
    Reproducible Reporting of the Collection and Evaluation of Annotations for Artificial Intelligence Models

    Article • Modern Pathology, April 2024, Elsevier

    Anna Ehinger

22. 
    Training pathologists to assess stromal tumour‐infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research

    Article • Histopathology, March 2024, Wiley

    Anna Ehinger

23. 
    Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab

    Article • npj Breast Cancer, February 2024, Springer Science + Business Media

    Anna Ehinger

24. 
    Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms

    Article • Breast Cancer Research, October 2023, Springer Science + Business Media

    Anna Ehinger

25. 
    Appendix S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

26. 
    Appendix S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

27. 
    Data from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

28. 
    Data from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

29. 
    Data from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

30. 
    Data from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

31. 
    Figure S1 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

32. 
    Figure S1 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

33. 
    Figure S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

34. 
    Figure S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

35. 
    Figure S2 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

36. 
    Figure S2 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

37. 
    Figure S2 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

38. 
    Figure S2 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

39. 
    Figure S3 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

40. 
    Figure S3 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

41. 
    Figure S3 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

42. 
    Figure S3 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

43. 
    Figure S4 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

44. 
    Figure S4 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

45. 
    Figure S5 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

46. 
    Figure S5 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

47. 
    Figure S6 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

48. 
    Figure S6 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

49. 
    Supplementary Legend from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

50. 
    Supplementary Legend from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

51. 
    Table S1 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

52. 
    Table S1 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

53. 
    Table S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

54. 
    Table S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

55. 
    Table S2 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

56. 
    Table S2 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

57. 
    Table S2 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

58. 
    Table S2 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

59. 
    Table S3 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

60. 
    Table S3 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

61. 
    Table S3 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

62. 
    Table S3 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

63. 
    Table S4 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

64. 
    Table S4 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

65. 
    Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study

    Article • Modern Pathology, October 2022, Elsevier

    Anna Ehinger

66. 
    How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer

    Article • Cancers, August 2022, MDPI AG

    Anna Ehinger

67. 
    RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

    Article • npj Breast Cancer, August 2022, Springer Science + Business Media

    Anna Ehinger

68. 
    Pilot study to evaluate tools to collect pathologist annotations for validating machine learning algorithms

    Article • Journal of Medical Imaging, July 2022, SPIE

    Anna Ehinger

69. 
    Development of Training Materials for Pathologists to Provide Machine Learning Validation Data of Tumor-Infiltrating Lymphocytes in Breast Cancer

    Article • Cancers, May 2022, MDPI AG

    Anna Ehinger

70. 
    52P RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

    Article • Annals of Oncology, May 2022, Elsevier

    Anna Ehinger

71. 
    The Prognostic Role of Intratumoral Stromal Content in Lobular Breast Cancer

    Article • Cancers, February 2022, MDPI AG

    Anna Ehinger

72. 
    The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    Article • npj Breast Cancer, December 2021, Springer Science + Business Media

    Khalid El Bairi, Anna Ehinger, Dr Stephen M Hewitt

73. 
    Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions

    Article • Nature Communications, October 2021, Springer Science + Business Media

    Anna Ehinger

74. 
    An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • Clinical Cancer Research, June 2021, American Association for Cancer Research (AACR)

    Anna Ehinger

75. 
    Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer

    Article • JNCI Cancer Spectrum, March 2021, Oxford University Press (OUP)

    Anna Ehinger

76. 
    Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study

    Article • Cancers, March 2021, MDPI AG

    Anna Ehinger

77. 
    Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer

    Article • Breast Cancer Research, February 2021, Springer Science + Business Media

    Anna Ehinger

78. 
    Molecular analyses of triple-negative breast cancer in the young and elderly

    Article • Breast Cancer Research, February 2021, Springer Science + Business Media

    Anna Ehinger

79. 
    Difficulties in diagnostics of lung tumours in biopsies: an interpathologist concordance study evaluating the international diagnostic guidelines

    Article • Journal of Clinical Pathology, February 2021, BMJ

    Anna Ehinger

80. 
    Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

    Article • Nature Communications, September 2020, Springer Science + Business Media

    Dr. Taobo Hu, Dr Elizabeth L Christie, Anna Ehinger

81. 
    The mutational landscape of the SCAN ‐B real‐world primary breast cancer transcriptome

    Article • EMBO Molecular Medicine, September 2020, EMBO

    Anna Ehinger

82. 
    Sex differences in oncogenic mutational processes

    Article • Nature Communications, August 2020, Springer Science + Business Media

    Dr. Taobo Hu, Dr Elizabeth L Christie, Anna Ehinger

83. 
    Abstract CT074: Pre-existing ESR1 mutations in early-stage primary breast cancer predict failure of endocrine therapy and poor survival

    Article • Cancer Research, August 2020, American Association for Cancer Research (AACR)

    Anna Ehinger

84. 
    Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers

    Article • Nature Communications, July 2020, Springer Science + Business Media

    Anna Ehinger

85. 
    Spatial Deconvolution of HER2-positive Breast Tumors Reveals Novel Intercellular Relationships

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Anna Ehinger

86. 
    Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer

    Article • npj Breast Cancer, July 2020, Springer Science + Business Media

    Anna Ehinger

87. 
    Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492).

    Article • Journal of Clinical Oncology, May 2020, American Society of Clinical Oncology (ASCO)

    Anna Ehinger

88. 
    Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

    Article • npj Breast Cancer, May 2020, Springer Science + Business Media

    Khalid El Bairi, Anna Ehinger, Dr Stephen M Hewitt

89. 
    Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    Article • npj Breast Cancer, May 2020, Springer Science + Business Media

    Khalid El Bairi, Anna Ehinger, Dr Stephen M Hewitt

90. 
    Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

    Article • npj Breast Cancer, May 2020, Springer Science + Business Media

    Khalid El Bairi, Anna Ehinger, Dr Stephen M Hewitt

91. 
    The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

    Article • The Journal of Pathology, April 2020, Wiley

    Anna Ehinger, Khalid El Bairi, Dr Stephen M Hewitt

92. 
    Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study

    Article • Cancer Research, February 2020, American Association for Cancer Research (AACR)

    Anna Ehinger

93. 
    UK Interdisciplinary Breast Cancer Symposium 2020

    Article • Breast Cancer Research and Treatment, February 2020, Springer Science + Business Media

    Anna Ehinger

94. 
    Pan-cancer analysis of whole genomes

    Article • Nature, February 2020, Springer Science + Business Media

    Dr. Taobo Hu, Anna Ehinger, Professor Daniel S. Brewer, Dr Elizabeth L Christie

95. 
    The Mutational Landscape of the SCAN-B Real-World Primary Breast Cancer Transcriptome

    Article • January 2020, Cold Spring Harbor Laboratory Press

    Anna Ehinger

96. 
    Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer

    Article • PLOS One, December 2019, PLOS

    Anna Ehinger

97. 
    Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study

    Article • Nature Medicine, September 2019, Springer Science + Business Media

    Anna Ehinger

98. 
    Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series

    Article • Scientific Reports, August 2019, Springer Science + Business Media

    Anna Ehinger

99. 
    Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer

    Article • Breast Cancer Research and Treatment, August 2019, Springer Science + Business Media

    Anna Ehinger

100. 
     Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort

     Article • Clinical Cancer Research, July 2019, American Association for Cancer Research (AACR)

     Anna Ehinger

101. 
     Refinement of breast cancer molecular classification by miRNA expression profiles

     Article • BMC Genomics, June 2019, Springer Science + Business Media

     Anna Ehinger

102. 
     Analytical validation of a standardized scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicenter collaboration

     Article • Histopathology, April 2019, Wiley

     Anna Ehinger

103. 
     Stability of oestrogen and progesterone receptor antigenicity in formalin-fixed paraffin-embedded breast cancer tissue over time

     Article • August 2018, Wiley

     Anna Ehinger

104. 
     Multidimensional transcriptomics provides detailed information about immune cell distribution and identity in HER2+ breast tumors

     Article • June 2018, Cold Spring Harbor Laboratory Press

     Anna Ehinger

105. 
     Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative

     Article • JCO Precision Oncology, March 2018, American Society of Clinical Oncology (ASCO)

     Anna Ehinger

106. 
     Abstract P1-06-01: Putting multigene signatures to the test: Prognostic assessment in population-based contemporary clinical breast cancer

     Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

     Anna Ehinger

107. 
     Abstract P2-02-09: Breast cancer subtype distribution and circulating tumor DNA in response to neoadjuvant chemotherapy: Experiences from a preoperative cohort within SCAN-B

     Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

     Anna Ehinger

108. 
     Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration

     Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

     Anna Ehinger

109. 
     Abstract P3-02-02: Concordance between immunohistochemical and gene-expression based subtyping of early breast cancer using core needle biopsies and surgical specimens - experices from SCAN-B

     Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

     Anna Ehinger

110. 
     Abstract P4-09-03: On the development and clinical value of RNA-sequencing-based classifiers for prediction of the five conventional breast cancer biomarkers: A report from the population-based multicenter SCAN-B study

     Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

     Anna Ehinger

111. 
     Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative

     Article • BJS, January 2018, Wiley

     Anna Ehinger

112. 
     Abstracts

     Article • Virchows Archiv, August 2017, Springer Science + Business Media

     Anna Ehinger

113. 
     Abstract P1-07-17: The SCAN-B study: 5-year summary of a large-scale population-based prospective breast cancer translational genomics platform covering a wide geography of Sweden (NCT02306096)

     Article • Cancer Research, February 2017, American Association for Cancer Research (AACR)

     Anna Ehinger

114. 
     Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013

     Article • Acta Oncologica, October 2016, Taylor & Francis

     Anna Ehinger

115. 
     Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer

     Article • PLOS One, March 2016, PLOS

     Anna Ehinger

116. 
     Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy

     Article • European Journal of Cancer, November 2015, Elsevier

     Anna Ehinger

117. 
     Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing

     Article • August 2015, Springer Science + Business Media

     Anna Ehinger

118. 
     Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

     Article • Genome Research, May 2015, Cold Spring Harbor Laboratory Press

     Anna Ehinger

119. 
     Abstract P6-08-43: Histological grade provides significant prognostic information in the discrimination between luminal A-like and luminal B-like HER-2 normal subtypes of breast cancer according to St Gallen 2013

     Article • Cancer Research, April 2015, American Association for Cancer Research (AACR)

     Anna Ehinger

120. 
     The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine

     Article • Genome Medicine, January 2015, Springer Science + Business Media

     Anna Ehinger

121. 
     Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

     Article • eLife, October 2014, eLife

     Professor Ming-Qing Du, Anna Ehinger, adrienne Flanagan, Professor Daniel S. Brewer

122. 
     Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

     Article • Science, July 2014, American Association for the Advancement of Science

     Anna Ehinger, Professor Daniel S. Brewer

123. 
     Processed pseudogenes acquired somatically during cancer development

     Article • Nature Communications, April 2014, Nature

     Anna Ehinger

124. 
     Acute pancreatitis evoked by small-cell lung carcinoma metastases and detected by endoscopic ultrasound

     Article • Endoscopy, March 2012, Thieme Publishing Group

     Anna Ehinger

125. 
     The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer

     Article • Journal of Ovarian Research, January 2012, Springer Science + Business Media

     Anna Ehinger

126. 
     G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua

     Article • Molecular Human Reproduction, May 2010, Oxford University Press (OUP)

     Anna Ehinger

127. 
     Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall

     Article • Breast Cancer Research and Treatment, January 2010, Springer Science + Business Media

     Anna Ehinger

128. 
     Histamine uptake by human endometrial cells expressing the organic cation transporter EMT and the vesicular monoamine transporter-2

     Article • Molecular Human Reproduction, June 2006, Oxford University Press (OUP)

     Anna Ehinger

129. 
     Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle

     Article • Molecular Human Reproduction, July 2004, Oxford University Press (OUP)

     Anna Ehinger

130. 
     Paracrine Stimulation of Capillary Endothelial Cell Migration by Endometrial Tissue Involves Epidermal Growth Factor and Is Mediated Via Up-Regulation of the Urokinase Plasminogen Activator Receptor

     Article • The Journal of Clinical Endocrinology & Metabolism, April 2001, Endocrine Society

     Anna Ehinger

131. 
     Breast metastases from pancreatic and ovarian carcinoma

     Article • Diagnostic Cytopathology, August 1999, Wiley

     Anna Ehinger